Sort
8,912 grants matching “sars cov 2”
COVID-19 surveillance in public buildings using vacuumed dust
$108,053Karen Dannemiller · Ohio State University · R21 · FY2023 · AI
Defining antiviral T cell responses restricted to the non-classical MHC class Ib molecule, Qa-1
$108,000Michael John Hogan · University Of Pennsylvania · K22 · FY2025 · AI
Phylogenetic and computational methods for accurate and efficient analyses of large-scale metagenomics datasets
$108,000Lenore Pipes · University Of California Berkeley · K99 · FY2023 · GM
Investigating How ADP-ribosylation Impacts Innate Immunity During Coronavirus Infection
$108,000Anthony R Fehr · University Of Kansas Lawrence · K22 · FY2020 · AI
Understanding the Molecular Basis of Translation Inhibition by SARS-CoV-2 NSP14 and its Role in SARS-CoV-2 Immune Evasion
$108,000Chun Chieh Hsu · Rutgers Biomedical And Health Sciences · K22 · FY2024 · AI
Investigating the role of T cells in promoting post-acute memory deficits after COVID-19 in mice
$107,995Abigail Rose Vanderheiden · Washington University · K99 · FY2025 · AI
Immunity to SARS-CoV-2 After Natural Infection or Vaccination
$107,663Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Understanding T cell responses and T cell signaling in human airway organoids with SARS-CoV-2 infection
$107,532Arthur Weiss · University Of California, San Francisco · P01 · FY2020 · AI
Project 2
$107,532Jeroen Roose · University Of California, San Francisco · P01 · FY2020 · AI
An ethno-epidemiological study to advance HIV prevention and treatment for PWUD
$107,479Will Small · Simon Fraser University · R01 · FY2021 · DA
Administrative Core
$107,473David B. Weiner · Wistar Institute · P01 · FY2025 · AI
Utilizing All of Us data to examine the impact of COVID-19 on mental health among people living with HIV
$107,340Xiaoming Li · University Of South Carolina At Columbia · R01 · FY2022 · MH
Immuno-Serological Assays for Monitoring COVID19 in Patients with Hematologic Malignancies
$107,220Rong Fan · Yale University · U01 · FY2024 · CA
FY21 ITCA NARCH XI
$107,116Maria Dadgar · Inter Tribal Council Of Arizona, Inc. · S06 · FY2022 · GM
Administrative Core
$107,104Karen M Ridge · Northwestern University At Chicago · P01 · FY2025 · HL
Household transmission of COVID19 in Costa Rica
$107,030D. Rebecca Prevots · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Task V7: Clinical and NHP Sample Testing for SARS-CoV-2 Vaccine Candidates
$106,598Thomas Rudge · Battelle Centers/Pub Hlth Res & Evaluatn · N01 · FY2021 · AI
Pre-existing cross-reactive antibodies to the SARS CoV-2 spike in sera from subjects in developing countries
$106,509James L Arthos · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Glycopolymer Inhibitors of Heparan Sulfate Proteoglycan Binding Pathogens
$106,500Katherine D McReynolds · California State University Sacramento · SC3 · FY2021 · GM
Glycopolymer Inhibitors of Heparan Sulfate Proteoglycan Binding Pathogens
$106,500Katherine D McReynolds · California State University Sacramento · SC3 · FY2024 · GM
Glycopolymer Inhibitors of Heparan Sulfate Proteoglycan Binding Pathogens
$106,500Katherine D McReynolds · California State University Sacramento · SC3 · FY2022 · GM
Glycopolymer Inhibitors of Heparan Sulfate Proteoglycan Binding Pathogens
$106,500Katherine D McReynolds · California State University Sacramento · SC3 · FY2023 · GM
SARS-CoV-2 Studies
$106,370Douglas Bell · National Institute Of Environmental Health Sciences · ZIA · FY2024 · ES
Administrative Core
$106,216Karen M Ridge · Northwestern University At Chicago · P01 · FY2024 · HL
Interrogating inflammatory responses to SARS-CoV-2 infection in vivo
$105,946Katrin Mayer-Barber · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI